Skip to main content

Organon & Co.

For the period ended Sep 30, 2024. Filed Nov 1, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 1, 2024

OGN$13.85-0.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(Unaudited, $ in millions except shares in thousands and per share amounts)

September 30, 2024December 31, 2023
Assets
Current Assets:
Cash and cash equivalents$763$693
Accounts receivable (net of allowance for doubtful accounts of $13 in 2024 and $9 in 2023)1,6851,744
Inventories (excludes inventories of $130 in 2024 and $110 in 2023 classified in Other assets)1,3831,315
Other current assets925756
Total Current Assets4,7564,508
Property, plant and equipment, net1,2041,183
Goodwill4,6034,603
Intangibles, net763533
Other assets1,4261,231
Total Assets$12,752$12,058
Liabilities and Equity
Current Liabilities:
Current portion of long-term debt$10$9
Trade accounts payable1,0921,314
Accrued and other current liabilities1,4581,389
Income taxes payable230206
Total Current Liabilities2,7902,918
Long-term debt8,7398,751
Deferred income taxes5647
Other noncurrent liabilities674412
Total Liabilities12,25912,128
Contingencies (Note 15)
Organon & Co. Stockholders’ Equity (Deficit):
Common stock, $0.01 par valueAuthorized - 500,000Issued and outstanding - 257,539 in 2024 and 255,626 in 202333
Additional paid-in capital8625
Retained earnings975443
Accumulated other comprehensive loss(571)(541)
Total Stockholders’ Equity (Deficit)493(70)
Total Liabilities and Stockholders’ Equity (Deficit)$12,752$12,058

-5-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.